Immunic (IMUX) Minority Interest (2013 - 2014)

Immunic's (IMUX) quarterly Minority Interest came in at $103.3 million in Q1 2014, up 25.86% quarter-over-quarter from $82.1 million in Q4 2013.

Immunic (IMUX) Minority Interest (2013 - 2014) Analysis & Trends

Immunic has disclosed Minority Interest across 2 years of filings, most recently posting $103.3 million for Q1 2014.

Minority Interest for Q1 2014 came in at $103.3 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2014 was $103.3 million (changed N/A YoY), and the FY2013 annual result was $82.1 million, changed N/A from the prior year.
Minority Interest came in at $103.3 million for Q1 2014 at Immunic, up from $82.1 million in the prior quarter.
In the past five years, Minority Interest ranged from a high of $103.3 million in Q1 2014 to a low of $82.1 million in Q4 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Immunic	431.25 Mn	244.62 Mn	-

Download Data

Date	Value
Mar 31, 2014	103.35 Mn
Dec 31, 2013	82.12 Mn